Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Medline reported net sales of $7.8 billion in Q4 2025, a 14% increase year-over-year; net income was $180 million, a 37.7% decrease year-over-year.
Net sales for the fourth quarter of 2025 were $7.8 billion, an increase of 14.8% from $6.8 billion in the fourth quarter of 2024, with organic sales¹ growing by 14.4%. The growth was primarily driven by higher volume, with both the Medline brand and supply chain solutions business segments delivering strong growth.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Recommended Reading


